Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Darke

Showing results (71-80 of 215) with videos related to

Pageof 22
Sort By:
Journal of Clinical Pharmacology|February 27, 2007
Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutyninJoseph L Reiz, Paulette Salem, Andrew C Darke
Tissue Antigens|May 1, 1991
A comparison of the reactivity of HLA-Aw33.1 and Aw33.2 with the 10th and 11th Workshop reagentsJ Street, H Fussell, T Mills, et al.
Tissue Antigens|March 1, 1979
HLA-A and B antigen frequencies in an asbestos exposed population with normal and abnormal chest radiographsC Darke, M M Wagner, G H McMillan
The Journal of International Medical Research|January 1, 1983
Open safety-in-use trial of a new high-potency antacid productG J Pawlowski, A Krondl, A C Darke
Lancet (London, England)|June 6, 1970
Significance of HL-A cytotoxic antibodies in Rh haemolytic diseaseG H Tovey, C Darke, I D Fraser
HLA|September 6, 2016
A further HLA-DRB1*15 family allele - DRB1*15:112J Street, C Harvey, J Johnson, et al.
Tissue Antigens|November 30, 2013
A new HLA-A*01 allele - A*01:139J Street, J Johnson, J Pepperall, et al.
Tissue Antigens|February 7, 2014
HLA-A*26:92-a further allele possessing a segment of A*02:01:01:01J Street, J Johnson, J Pepperall, et al.
Journal of Clinical & Laboratory Immunology|December 1, 1987
Cellular immunity to collagen in periodontal disease: role of T, B lymphocytes and adherent cellsA Amer, G Singh, C Darke, et al.
Tissue Antigens|October 1, 1986
Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3A Amer, G Singh, C Darke, et al.
Pageof 22

Showing results (71-80 of 215) with videos related to

Sort By:
Pageof 22
Journal of Clinical Pharmacology|February 27, 2007
Pharmacokinetics and pharmacodynamics of once-daily controlled-release oxybutynin and immediate-release oxybutyninJoseph L Reiz, Paulette Salem, Andrew C Darke
Tissue Antigens|May 1, 1991
A comparison of the reactivity of HLA-Aw33.1 and Aw33.2 with the 10th and 11th Workshop reagentsJ Street, H Fussell, T Mills, et al.
Tissue Antigens|March 1, 1979
HLA-A and B antigen frequencies in an asbestos exposed population with normal and abnormal chest radiographsC Darke, M M Wagner, G H McMillan
The Journal of International Medical Research|January 1, 1983
Open safety-in-use trial of a new high-potency antacid productG J Pawlowski, A Krondl, A C Darke
Lancet (London, England)|June 6, 1970
Significance of HL-A cytotoxic antibodies in Rh haemolytic diseaseG H Tovey, C Darke, I D Fraser
HLA|September 6, 2016
A further HLA-DRB1*15 family allele - DRB1*15:112J Street, C Harvey, J Johnson, et al.
Tissue Antigens|November 30, 2013
A new HLA-A*01 allele - A*01:139J Street, J Johnson, J Pepperall, et al.
Tissue Antigens|February 7, 2014
HLA-A*26:92-a further allele possessing a segment of A*02:01:01:01J Street, J Johnson, J Pepperall, et al.
Journal of Clinical & Laboratory Immunology|December 1, 1987
Cellular immunity to collagen in periodontal disease: role of T, B lymphocytes and adherent cellsA Amer, G Singh, C Darke, et al.
Tissue Antigens|October 1, 1986
Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3A Amer, G Singh, C Darke, et al.
Pageof 22